Breakpoint cluster regions of the AML-1 and ETO genes contain MAR elements and are preferentially associated with the nuclear matrix in proliferating HEL cells

Journal of Cell Science

Volumn 117, Issue 19, 2004, Pages 4583-4590

  Iarovaia, Olga V ^a   Shkumatov, Petr ^a   Razin, Sergey V ^a  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

Author keywords

Chromosomal rearrangements; FISH; Nuclear halos; Nuclear matrix; Topoisomerase II; Translocations t(8; 21)

Indexed keywords

DNA FRAGMENT; NUCLEAR MATRIX PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETO; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS MATRIX; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA SEQUENCE; ERYTHROLEUKEMIA CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE LOCATION; GENE MAPPING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA PRIMERS; DNA-BINDING PROTEINS; HUMANS; IN SITU HYBRIDIZATION; MATRIX ATTACHMENT REGIONS; NUCLEAR MATRIX; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 5444235365     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01332     Document Type: Article

References (51)

1. Ahuja, H. G., Felix, C. A. and Aplan, P. D. (2000). Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations. Genes Chromosomes Cancer 29 96-105.
2. Auxenfants, E., Morel, P., Lai, J. L., Sartiaux, C., Detourmignies, L., Bauters, F. and Fenaux, P. (1992). Secondary acute lymphoblastic leukemia with t (4;11): report on two cases and review of the literature. Ann. Hematol. 65, 143-146.
3. Balajee, A. S., Dominguez, I., Bohr, V. A. and Natarajan, A. T. (1996). Immunofluorescent analysis of the organization of telomeric DNA sequences and their involvement in chromosomal aberrations in hamster cells. Mut. Res. 372, 163-172.
4. Berezney, R. and Coffey, D. S. (1977). Nuclear matrix: isolation and characterization of a framework structure from rat liver nuclei. J. Cell Biol. 73, 616-637.
5. Boulikas, T. (1995). Chromatin domains and prediction of MAR sequences. Int. Rev. Cytol. 162A, 279-388.
6. Boyle, S., Gilchrist, S., Bridger, J. M., Mahy, N. L., Ellis, J. A. and Bickmore, W. A. (2001). The spatial organization of human chromosomes within the nuclei of normal and emerin-mutant cells. Hum. Mol. Genet. 10, 211-219.
7. Bystritskiy, A. and Razin, S. V. (2004). Breakpoint clusters: reason or consequence. Crit. Rev. Eukar. Gene Expr. 14 65-78.
8. Ciejek, E. M., Tsai, M.-J. and O'Malley, B. W. (1983). Actively transcribed genes are associated with the nuclear matrix. Nature 306, 607-609.
9. Cockerill, P. N. and Garrard, W. T. (1986). Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the nenhancer in a region containing topoisomerase II sites. Cell 44 273-282.
10. Davis, J. N., McGhee, L. and Meyers, S. (2003). The ETO (MTG8) gene family. Gene 303, 1-10.
11. Elsasser, A., Franzen, M., Kohlmann, A., Weisser, M., Schnittger, S., Schoch, C., Reddy, V. A., Burel, S., Zhang, D. E., Ueffing, M. et al. (2003). The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-Jun protein expression via the proximal AP-1 site of the c-Jun promoter in an indirect, JNK-dependent manner. Oncogene 22, 5646-5657.
12. + hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease. Blood 88, 1813-1823.
13. Felix, C. A. (1998). Secondary leukemias induced by topoisomerase-targeted drugs. Biochim. Biophys. Acta 1400, 233-255.
14. Fernandes, D. J. and Catapano, C. V. (1995). The nuclear matrix as a site of anticancer drug action. Int. Rev. Cytol. 162, 539-576.
15. Gale, K. C. and Osheroff, N. (1992). Intrinsic intermolecular DNA ligation activity of eukaryotic topoisomerase II. Potential roles in recombination. J. Biol. Chem. 267, 12090-12097.
16. Geng, J. P., Tong, J. H., Dong, S., Wang, Z. Y., Chen, S. J., Chen, Z., Zelent, A., Berger, R. and Larsen, C. J. (1993). Localization of the chromosome 15 breakpoints and expression of multiple PML-RAR alpha transcripts in acute promielocytic leukemia: a study of 28 Chinese patients. Leukemia 7, 20-26.
17. Gerdes, M. G., Carter, K. C., Moen, P. T. J. and Lawrence, J. B. (1994). Dynamic changes in the higher-level chromatin organization of specific sequences revealed by in situ hybridization to nuclear halos. J. Cell Biol. 126, 289-304.
18. Gromova, I. I., Thomsen, B. and Razin, S. V. (1995a). Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei. Proc. Natl. Acad. Sci. USA 92, 102-106.
19. Gromova, I. I., Nielsen, O. F. and Razin, S. V. (1995b). Long-range fragmentation of the eukaryotic genome by exogenous and endogenous nucleases proceeds in a specific fashion via preferential DNA cleavage at matrix attachment sites. J. Biol. Chem. 270, 18685-18690.
20. Henglein, B., Synovzik, H., Groitl, P., Bornkamm, G. W., Hartl, P. and Lipp, M. (1989). Three breakpoints of variant t(2:8) translocations in Burkett's lymphoma cells fall within a region 140 kilobases distal from c-myc. Mol. Cell. Biol. 9, 2105-2113.
21. Iarovaia, O., Hancock, R., Lagarkova, M., Miassod, R. and Razin, S. V. (1996). Mapping of genomic DNA loop organization in a 500-kilobase region of the Drosophila X chromosome by the topoisomerase II-mediated DNA loop excision protocol. Mol. Cell. Biol. 16, 302-308.
22. Iarovaia, O. V., Bystritskiy, A., Ravcheev, D., Hancock, R. and Razin, S. V. (2004). Visualization of individual DNA loops and a map of loop-domains in the human dystrophin gene. Nucleic Acids Res. 32, 2079-2086.
23. Jackson, D. A. and Cook, P. R. (1985). Transcription occurs at a nucleoskeleton. EMBO J. 4, 919-925.
24. Lambert, J. M. and Fernandes, D. J. (2000). Topoisomerase II cleavable complex formation within DNA loop domains. Biochem. Pharmacol. 60, 101-109.
25. Le, X. F., Claxton, D., Kornblau, S., Fan, Y. H., Mu, Z. M. and Chang, K. S. (1998). Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemia. Eur. J. Haematol. 60, 217-225.
26. Lovett, B. D., Lo Nigro, L., Rappaport, E. F., Blair, I. A., Osheroff, N., Zheng, N., Megonigal, M. D., Williams, W. R., Nowell, P. C. and Felix, C. A. (2001). Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation. Proc. Natl. Acad. Sci. USA 98, 9802-9807.
27. Mahy, N. L., Perry, P. E. and Bickmore, W. A. (2002). Gene density and transcription influence the localization of chromatin outside of chromosome territories detectable by FISH. J. Cell Biol. 159, 753-763.
28. Maniatis, T., Fritsch, E. F. and Sambrook, J. (1982). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
29. Maraschin, J., Dutrillaux, B. and Aurias, A. (1990). Chromosome aberrations induced by etoposide (VP-16) are not random. Int. J. Cancer. 46, 808-812.
30. Maya-Mendoza, A. and Aranda-Anzaldo, A. (2003). Positional mapping of specific DNA sequences relative to the nuclear substructure by direct polymerase chain reaction on nuclear matrix-bound templates. Anal. Biochem. 313, 196-207.
31. Mirkovitch, J., Mirault, M.-E. and Laemmli, U. K. (1984). Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold. Cell 39, 223-232.
32. Parada, L. A., McQueen, P. G., Munson, P. J. and Misteli, T. (2002). Conservation of relative chromosome positioning in normal and cancer cells. Curr. Biol. 12, 1692-1697.
33. Ragoczy, T., Telling, A., Sawado, T., Groudine, M. and Kosak, S. T. (2003). A genetic analysis of chromosome territory looping: diverse roles for distal regulatory elements. Chromosome Res. 11, 513-525.
34. Ratsch, A., Joos, S., Kioschis, P. and Lichter, P. (2002). Topological organization of the MYC/IGK locus in Burkett's lymphoma cells assessed by nuclear halo preparations. Exp. Cell. Res. 273, 12-20.
35. Razin, S. V. (1987). DNA interaction with the nuclear matrix and spatial organization of replication and transcription. BioEssays 6, 19-23.
36. Razin, S. V. (1999). Chromosomal DNA loops may constitute basic units of the genome organization and evolution. Crit. Rev. Eukaryotic Gene Expr. 9, 279-283.
37. Razin, S. V. (2001). The nuclear matrix and chromosomal DNA loops: is there any correlation between partitioning of the genome into loops and functional domains. Cell. Mol. Biol. Lett. 6, 59-69.
38. Razin, S. V., Mantieva, V. L. and Georgiev, G. P. (1979). The similarity of DNA sequences remaining bound to scaffold upon nuclease treatment of interphase nuclei and metaphase chromosomes. Nucleic Acids Res. 7, 1713-1735.
39. Razin, S. V., Petrov, P. and Hancock, R. (1991). Precise localization of the α-globin gene cluster within one of the 20- to 300-kilobase DNA fragment released by cleavage of chicken chromosomal DNA at topoisomerase II site in vivo: evidence that the fragment are DNA loops or domains. Proc. Natl. Acad. Sci. USA 88, 8515-8519.
40. Razin, S. V., Hancock, R., Iarovaia, O., Westergaard, O., Gromova, I. and Georgiev, G. P. (1993). Structural-functional organization of chromosomal DNA domains. Cold Spring Harbor Symp. Quant. Biol. 58, 25-35.
41. Robinson, S. I., Small, D., Idzerda, R., McKnight, G. S. and Vogelstein, B. (1983). The association of active genes with the nuclear matrix of the chicken oviduct. Nucleic Acids Res. 15, 5113-5130.
42. Roix, J. J., McQueen, P. G., Munson, P. J., Parada, L. A. and Misteli, T. (2003). Spatial proximity of translocation-prone gene loci in human lymphomas. Nat. Genet. 34, 287-291.
43. Rowley, J. D. (1993). Rearrangements involving chromosome band 11q23 in acute leukaemia. Semin. Cancer Biol. 4 377-385.
44. Shibuya, M. L., Ueno, A. M., Vannais, D. B., Craven, P. A. and Valdren, C. A. (1994). Megabase pair deletions in mutant mammalian cells following exposure to amsacrine, an inhibitor of DNA topoisomerase II. Cancer Res. 54, 1092-1097.
45. Super, H. J., McCabe, N. R., Thirman, M. J., Larson, R. A., le Beau, M. M., Pedersen-Bjergaard, J., Philip, P., Diaz, M. O. and Rowley, J. D. (1993). Rearrangements of MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82, 3705-3711.
46. Svetlova, E. and Razin, S. V. (2001). The loop pattern of chromosomal DNA may significantly differ in AT-rich and GC-rich isochores. Doklady Biochem. Biophys. 377, 135-136.
47. Svetlova, E. Y., Razin, S. V. and Debatisse, M. (2001). Mammalian recombination hot spot and DNA loop anchorage region: a model for the study of common fragile sites. J. Cell. Biochem. 36, 170-178.
48. Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E. and Hiebert, S. W. (1998). The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol. Cell. Biol. 18, 322-333.
49. Whitmarsh, R. J., Saginario, C., Zhuo, Y., Hilgenfeld, E., Rappaport, E. F., Megonigal, M. D., Carroll, M., Liu, M., Osheroff, N., Cheung, N. K. et al. (2003). Reciprocal DNA topoisomerase II cleavage events at 5′-TATTA-3′ sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing. Oncogene 22, 8448-8459.
50. Zhang, Y., Hillion, J., Tong, J. H., Cao, Q., Chen, S. J., Berger, R. and Chen, Z. (1994). AML-1 gene rearrangement and AML-1-ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8;21). Leukemia 8, 729-734.
51. Zhang, Y., Strissel, P., Strick, R., Chen, J., Nucifora, G., le Beau, M. M., Larson, R. A. and Rowley, J. D. (2002). Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia. Proc. Natl. Acad. Sci. USA 99, 3070-3075.